SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001079973-23-000982
Filing Date
2023-07-18
Accepted
2023-07-18 16:01:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G l1cap_13g.htm SC 13G 34390
  Complete submission text file 0001079973-23-000982.txt   36058
Mailing Address 161A SHEDDEN ROAD ONE ARTILLERY COURT P.O. BOX 10085 GRAND CAYMAN E9 KY1-1001
Business Address 161A SHEDDEN ROAD ONE ARTILLERY COURT P.O. BOX 10085 GRAND CAYMAN E9 KY1-1001 646-688-5654
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by) CIK: 0001702202 (see all company filings)

IRS No.: 981241877 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Subject) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93211 | Film No.: 231094247
SIC: 2834 Pharmaceutical Preparations